著書

1) : GERD. : 2003-2004, 87-90 2003 2 :. : 2003 344 2003 3 :. : 8 943-945 2003 4 :. : 2003 5 : Mallory-Weiss. : 192-203 2003 6 :. : 80-81 2003 7 : B. : 112-114 2003 8 :. : 45 123-124 2003 9 : : 2 801-804 2003 10 :. : 2 804-807 2003 11 : 21. : 66 20 21 116-119 2003 12 :. : 2004 351-352 2004 13 :. : Annual Review2004 204-208 2004 14 : 29. : 1

207-212 2004 15 : Barrett. : 60-62 2004 16 :. : EBM 323-326 2004 17 : CGRP) : 657-661 2004 18 :. : MOOK 222-225 2004 19 : 27 : 858-859 2004 20 : 28 : 860-861 2004 21 : : 120-123 2004 22 : Part1 GERD. : Helicobacter pylori Q&A 19-20 2004 23 :. : UPDETA 356-360 2004 24 : GERD. : 96 GERD 23-33 2004 25 :. : 528-531 2004 26 :. : 54-57 2004 27 :. : 2 411-412 2004 28 : Mallory-Weiss. : 2 418 2004 2

1 Hamamoto S, Fukuda R, Ishimura N, Rumi MAK, Kazumori H, Uchida Y, Kadowaki Y, Ishihara S, Kinoshita Y. 9-cis retinoic acid enhances the anti-viral effect of interferon on hepatitis C virus replication through increased expression of type-i interferon receptor. Journal of Laboratory and Clinical Medicine 141 (1): 58-66, 2003 2 Hiroshi Sato, Kousaku Kawashima, Mika Yuki, Hideaki Kazumori, Rumi MAK, Ortega-Cava CF, Shunji Ishihara, Yoshikazu Kinoshita. Lafutidine, a novel histamine H2-receptor antagonist, increases serum calcitonin gene-related peptide in rats after water immersion-restraint stress. Journal of Laboratory and Clinical Medicine 141 (2): 102-105, 2003 3) Kyoichi Adachi, Hirofumi Fujishiro, Takafumi Mihara, Yoshinori Komazawa, Yoshikazu Kinoshita. Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 18 (2): 168-171, 2003 4) Yoshinori Komazawa, Kyoichi Adachi, Takafumi Mihara, Masahiro Ono, Akira Kawamura, Hirofumi Fujishiro and Yoshikazu Kinoshita. Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subject without Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 18 (6): 678-682, 2003 5) Fujishiro H, Adachi K, Imaoka T, Kohge N, Kawamura A, Komazawa Y, Ono M, Yuki M, Sato H, Amano Y, Ishihara S, Kinoshita Y. Analysis of urgent colonoscopy for acute lower intestinal bleeding. Digestive Endoscopy 15 (2): 117-120, 2003 6) Adachi K, Hashimoto T, Hamamoto N, Hirakawa K, Niigaki M, Miyaoka T, Taniura N, Ono M, Kaji T, Suetsugu H, Yagi J, Komazawa Y, Mihara T, Katsube T, Fujishiro H, Shizuku T, Hattori S, Yamamoto S, Kinoshita Y. Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole and rabeprazole. Journal of Gastroenterology and Hepatology 18: 1392-1398, 2003 7) Adachi K, Arima N, Takashima T, Miyaoka Y, Yuki M, Ono M, Komazawa Y, Kawamura A, Fujishiro H, Ishihara S, Kinoshita Y. Pulse wave velocity and cardiovascular risk factors in subjects with Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 18 (7): 771-777, 2003 8) Kinoshita Y, Adachi K, Fujishiro H. Review article: Therapeutic approaches to reflux diseases, focusing on acid secretion. Journal of Gastroenterology 38 (suppl 15): 13-19, 2003 9) Yuji Amano, Yoshinori Komazawa, Norihisa Ishimura, Hirofumi Fujishiro, Shunji Ishihara, Kyoichi Adachi and Yoshikazu Kinoshita. Prevalence of reflux esophagitis in patients with 3

duodenal ulcer and gastric ulcer. Journal of Gastroenterology 38 (5): 514-515, 2003 10) Kyoichi Adachi, Yoshinori Komazawa, Hirofumi Fujishiro, Takafumi Mihara, Masahiro Ono, Mika Yuki, Akira Kawamura, Mohammad Azharul Karim Rumi, Yuji Amano and Yoshikazu Kinoshita. Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative cases: effects of different regimens. Journal of Gastroenterology 38 (9): 830-835, 2003 11). GERD GERD. 669: 37-40, 2003 12),,,,,,.. 18 (2): 241-243, 2003 13) Kyoichi Adachi, Tomoyuki Hashimoto, Shunji Ishihara, Hirofumi Fujishiro, Shuichi Sato, Hiroshi Sato, Yuji Amano, Shuzo Hattori, Yoshikazu Kinoshita. Comparison of five day Helicobacter pylori eradication regimens: rabeprazole-based and omeprazole-based with and without omeprazole pretreatment -open, prospective, randomized, multicenter study. Current Therapeutic Research 64: 412-421, 2003 14) Norihisa Ishimura, Kunihiro Yamasawa, Mohammad Azharul Karim Rumi, Yasunori Kadowaki, Shunji Ishihara, Yuji Amano, Yoshinori Nio, Tetsuya Higami, Yoshikazu Kinoshita. BRAF and K-ras gene mutations in human pancreatic cancers Cancer letters 199: 169-173, 2003 15),,,,,,,,,,.. 18 (4): 503-505, 2003 16),.. G. I. Research 11 (2): 154-157, 2003 17),,.. 33 (4): 427-430, 2003 18),,. Quiz 109. Clinician 49 (517): 122-124, 2003 19),,,,,,.. 6 (2): 231-234, 2003 20),,,,. PPI H2 H2RA PPI H2RA PPI. Therapeutic Research 24 (5): 789-793, 2003 21) Masahiro Ono, Hiroshi Sato, Hideaki Kazumori, Mika Yuki, Mohammad Azharul Karim 4

Rumi, Cesar Francisco Ortega-Cava, Yasunobu Ishihara, Shunji Ishihara, Kyoichi Adachi, Yoshikazu Kinoshita. Effect of a gastrin/cck-b receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats. The Journal of Laboratory and Clinical Medicine 142: 364-371, 2003 22) Yuki T, Ishihara S, Rumi M, Ortega-Cava CF, Kadowaki Y, Kazumori H, Yuki M, Wada T, Miyaoka Y, Yoshino N, Kinoshita Y. Expression of midkine and receptor-like protein tyrosine phosphatase (RPTP)- genes in the rat stomach and the influence of rebamipide. Alimentary Pharmacology and Therapeutics 18 (suppl2): 106-112, 2003 23) Ortega-Cava CF, Ishihara S, Rumi MK, Kawashima K, Ishimura N, Kazumori H, Udagawa J, Kadowaki Y, Kinoshita Y. Strategic compartmentalization of tall-like receptor 4 in the mouse gut. The Journal of Immunology 170 (8): 3977-3985, 2003 24). NUD. Medical Academy News 850: 12, 2003 25),. Colitic Cancer. 23: 98-102, 2003 26),,,,,,,,,,. Boerhaave. 18: 367-372, 2003 27),. NUD. 18: 445-451, 2003 28),,,.. 37: 517-529, 2003 29),,,,,,,,,,. OPZ H. pylori HP OPZ. 35: 1-4, 2003 30),. H2. Medicine and Pharma 4: 2-5, 2003 31),,,. PPI. Medical Tribune 36 (26): 38-39, 2003 32),.. Care Net 61 (7): 4, 2003 33),,. H. pylori. 23 (6): 884-888, 2003 34),.. 23: 967-970, 2003 35),,. H2. Medical Tribune 36 (30,31): 11-14, 2003 5

36). 1 2 3. 100: 1239, 2003 37),,.. 6: 448-453, 2003 38).. 89 2-11, 2003 39),,.. Medicina 40: 1476-1479, 2003 40),,. AGA 2002 in. 1: 127-133, 2003 41),,,,,,,. Barrett's surveillance. 30 (Suppl): 7-10, 2003 42),. GERD,. 54 : 327-333, 2003 43),.. 5 (2): 1-5, 2003 44).. MEDICAMENT NEWS 1780: 5-6, 2003 45),. NAB- nocturnal gastric acid breakthrough-. Current Review of Gastroenterology 8: 8-10, 2003 46),.. 80: 2251-2254, 2003 47). PPI QOL H2RA. CLINICIAN 50: 1015-1018, 2003 48),,. Helicobacter pylori Q&A No75 GERD Helicobacter Research 7: 559-561, 2003 49),,,,,. GERD Nocturnal gastric acid breakthrough. 15: 1715-1719, 2003 50).. 9: 1, 2003 51),,,,,,,,,,,.. 9: 91-95, 2003 52) Adachi K, Komazawa Y, Mihara T, Fujishiro H, Ishihara S, Amano Y, Kinoshita Y. Administration of H2 receptor antagonist with proton pump inhibitor is effective for 6

long-term control of refractory reflux esophagitis. Journal of Clinical Gastroenterology 38 (3): 297-298, 2004 53) Amano Y, Moriyama N, Suetsugu H, Ishimura N, Imaoka T, Komazawa Y, Fujishiro H, Ishihara S, Adachi K, Kinoshita Y. Which types of non-bleeding visible vessels in gastric peptic ulcers should be treated by endoscopic hemostasis? Journal of Gastroenterology and Hepatology 19 (1): 13-17, 2004 54) Youichi Miyaoka, Yasunori Kadowaki, Shunji Ishihara, Takayuki Ose, Hiroyuki Fukuhara, Hideaki Kazumori, Shin Takasawa, Hiroshi Okamoto, Tsutomu Chiba, Yoshikazu Kinoshita. Transgenic overexpression of Reg protein caused gastric cell proliferation and differentiation along parietal cell and chief cell lineages. Oncogene 23 (20): 3572-3579, 2004 55) Shuchin Tei, Naoto Kitajima, Shunji Ohara, Yoshifumi Inoue, Masaharu Miki, Toshiyuki Yamatani, Hiroshi Yamabe, Shunji Mishiro, Yoshikazu Kinoshita. Consumption of uncooked deer meat as a risk factor for hepatitis E virus infection: an age-and sex-matched case-control study. Journal of Medical Virology 74: 67-70, 2004 56) Kinoshita Y, Ishihara S. Is an intravenous histamine H2 receptor antagonist superior to an intravenous proton pump inhibitor in acid suppression? Journal of Gastroenterology 39 (1): 92-93, 2004 57) Amano Y, Komazawa Y, Ishimura N, Ohara S, Aimi M, Fujishiro H, Ishihara S, Adachi K, Kinoshita Y. Two cases of superficial cancer in Barrett's esophagus detected by chromoendoscopy with crystal violet. Gastrointestinal Endoscopy 59 (1): 143-146, 2004 58) Kinoshita Y, Ishihara S. Role of growth factors in the repair of gastric mucosal injury. Journal of Gastroenterology 39 (2): 202-203, 2004 59) Dhar DK, Udagawa J, Ishihara S, Otani H, Kinoshita Y, Takasawa S, Okamoto H, Kubota H, Fujii T, Tachibana M, Nagasue N. Expression of Regenerating Gene I in gastric adenocarcinomas: correlation with tumor differentiation status and patient survival. Cancer 100 (6): 1130-1136, 2004 60) Kinoshita Y, Ishihara S, Kadowaki Y, Fukui H, Chiba T. Review article: Reg protein is a unique growth factor of gastric mucosal cells. Journal of Gastroenterology 39 (6): 507-513, 2004 61) Adachi K, Furuta K, Katsube T, Fujisawa T, Azumi T, Fujishiro H, Ishihara S, Amano Y, Kinoshita Y. Nizatidine and cisapride increase salivary secretion in rats. Digestive Disease of Science 49 (3): 399-403, 2004 62) Amano Y, Kushiyama Y, Takahashi Y, Ishihara S, Adachi K, Kinoshita Y. Prevalence of ileo-colonic ulcerative lesions in chronic NSAIDs users. American Journal of 7

Gastroenterology 99 (6): 1193, 2004 63) Kinoshita Y. Treatment of GORD: Lifestyle advice and medication. Alimentary Pharmacology and Therapeutics 20 (suppl 8): 19-23, 2004 64) Ishihara S, Rumi MAK, Okuyama T, Kinoshita Y. Effect of prostaglandins on the regulation of tumor growth. Current Medicinal Chemistry-Anti-Cancer Agents 4: 379-387, 2004 65) Ishihara S, Rumi MAK, Kadowaki Y, Ortega-Cava CF, Yuki T, Yoshino N, Miyaoka Y, Kazumori H, Ishimura N, Amano Y, Kinoshita Y. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. The Journal of Immunology 173: 1406-1416, 2004 66) Ortega-Cava CF, Ishihara S, Kinoshita Y. Epithelial TLR5 is constitutively focalized to the mouse cecum and exhibit a distinctive down-regulation during experimental colitis. Gastroenterology 126 (suppl 2): A150, 2004 67) Fujisawa T, Adachi K, Komazawa Y, Mihara T, Katsube T, Azumi T, Furuta K, Rumi MAK, Ishihara S, Amano Y, Kinoshita Y. Helicobacter pylori infection prevents the tolerance of gastric acid suppressing effect of continuous H2 receptor antagonist therapy. Gastroenterology 126 (suppl 2): A535, 2004 68) Fujisawa T, Adachi K, Komazawa Y, Mihara T, Azumi T, Katsube T, Furuta K, Kazumori H, Kinoshita Y. Helicobacter pylori infection prevents the occurrence of the tolerance phenomenon of histamine H2 receptor antagonists. Alimentary Pharmacology and Therapeutics 20: 559-565, 2004 69) Amano Y, Ishihara S, Kushiyama Y, Yuki T, Takahashi Y, Chinuki D, Miyake T, Miyaoka Y, Rumi MAK, Ishimura N, Adachi K, Kinoshita Y. Barrett's esophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygemase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage. Alimentary Pharmacology and Therapeutics 20 (7): 793-802, 2004 70) Rumi MAK, Ishihara S, Kadowaki Y, Ortega-Cava CF, Kazumori H, Kawashima K, Yoshino N, Yuki T, Ishimura N, Kinoshita Y. Peroxisome proliferator-activated receptor -dependent and -independent growth inhibition of gastrointestinal tumor cells. Genes to Cells 9 (11): 1113-1123, 2004 71) Ponchon T, Makuuchi H, Morita Y, Fukuda M, Mitani T, Shirasaka D, Aoyama N, Amano Y, Moriyama I, Oose T, Kinoshita Y. Images of early cancer: esophageal squamous-cell carcinoma. Endoscopy 36: 811-820, 2004 72) Rumi MAK, Ishihara S, Kazumori H, Kadowaki Y, Kinoshita Y. Can PPAR ligands be 8

used in cancer therapy? Current Medical Chemistry-Anti-Cancer Agents 4 (6): 465-77, 2004 73) Kazumori H, Ishihara S, Rumi MAK, Ortega-Cava CF, Kadowaki Y, Kinoshita Y. Transforming growth factor directly augments histidine decarboxylase and vesicular monoamine transporter 2 production in rat enterochromaffin-like cells. American journal of physiology. Gastrointestinal and liver physiology 286: G508-G514, 2004 74),.. 101: 7-14, 2004 75). world wide topics Mod2 MDP. Nod1. 1: 77-79, 2004 76),.. 2004 77),.. G. I. Reseach 12: 99-109, 2004 78). FD. 6: 20-21, 2004 79),.. Medicina 41: 654-656, 2004 80),,,,,,. Barrett's surveillance crystal violet methylene blue. Therapeutic Research 25: 817-821, 2004 81). 2. 38: 507, 2004 82). Functional Dyspepsia. 38: 10, 2004 83),. IBD. 24: 1220-1224, 2004 84),,.. JOHNS 20: 1003-1006, 2004 85),,,,,. 35. 7 (3): 304-306, 2004 86),,,. Helicobacter pylori H2 H2RA tolerance. 36: 65-68, 2004 87),,,. Current Review of Gastroenterology 9: 2-7, 2004 88),,. Helicobacter pylori. Arterial Stiffness 6: 28-29, 2004 89). 9

. 1: 193, 2004 90),.. 1: 230-241, 2004 91),.. 81: 1443-1449, 2004 92),,,,. 2 nocturnal gastric acid break through NAB). 19: 1635-1640, 2004 93). Medical Tribune. 3: 6-7, 2004 94),,,. GERD. 66: 1-9, 2004 95),. Q&A. 101: 1243-1246, 2004 96). AGA Report. 31: 41-51, 2004 97),,.. G. I. Research 12: 463-469, 2004 98). 1.. Nikkei Medical 445: 150-151, 2004 99),.. 16: 31-34, 2004 100),,,,,,. H. pylori Toll-like receptor-4. 39 (6): 620-627, 2004 101),,,,,,,. COX-2 Barrett Barrett COX-2. 31 (suppl): 21-24, 2004 102),.. 11 (5): 12-17, 2004 Hideaki Kazumori, Shunji Ishihara, Yoshikazu Kinoshita: Transforming growth factor- directly augments histidine decarboxylase and vesicular monoamine transporter 2 production in rat enterochromaffin-like cells. 104th Annual Meeting of the American Gastroenterological Association. Orlando, USA, May 2003 2) Norihisa Ishimura, Ryo Fukuda, Tomoko Wada, Sachiko Hamamoto, Mohammad Azharul 10

Karim Rumi, Cesar Ortega, Yasunori Kadowaki, Shunji Ishihara, Yoshikazu Kinoshita: Ribavirin increases the expression of type I interferon receptor in human hepatoma cell lines. 104th Annual Meeting of the American Gastroenterological Association. Orlando, USA, May 2003 3) Kyoichi Adachi, Tomoyuki Hashimoto, Shunji Ishihara, Hirofumi Fujishiro, Shuichi Sato, Yuji Amano, Shuzo Hattori, Yoshikazu Kinoshita: Comparison of five day Helicobacter pylori eradication regimens: Rabeprazole-based and omeprazole-based with and without omeprazole pretreatment. 104th Annual Meeting of the American Gastroenterological Association. Orlando, USA, May 2003 4) Takafumi Yuki, Shunji Ishihara, Cesar F. Ortega-Cava, MAK Rumi, Tomoko Wada, Youichi Miyaoka, Nagisa Yoshino, Nobuyuki Moriyama, Norihisa Ishimura, Yasunori Kadowaki, Yuji Amano, Kyoichi Adachi, Yoshikazu Kinoshita: Role of midkine and receptor-like protein tyrosine phosphatase-x during epithelial regeneration in dextran sodium sulfate-induced colitis. 104th Annual Meeting of the American Gastroenterological Association. Orlando, USA, May 2003 5) Misa Niigaki, Syuichi Sato, Tomoko Wada, Youichi Miyaoka, Masatoshi Niigaki, Sachiko Hamamoto, MAK Rumi, Yoshikazu Kinoshita: Relationship between steatosis and hepatocarcinogenesis in chronic liver disease patients with hepatitis C virus. 104th Annual Meeting of the American Gastroenterological Association. Orlando, USA, May 2003 6) Cesar F. Ortega-Cava, Shunji Ishihara, Yoshikazu Kinoshita: Epithelial TLR5 is constitutively focalized to the mouse cecum and exhibit a distinctive down-regulation during experimental colitis. DIGESTIVE DISEASE WEEK 2004. New Orleans, USA, May 2004 7) Tomoo Fujisawa, Kyoichi Adachi, Yoshinori Komazawa, Takafumi Mihara, Tomoko Katsube, Takane Azumi, Kenji Furuta, Mohammad A. K. Rumi, Shunji Ishihara, Yuji Amano, Yoshikazu Kinoshita: Helicobacter pylori infection prevents the tolerance of gastric acid suppressing effect of continuous H2 receptor antagonist therapy. DIGESTIVE DISEASE WEEK 2004. New Orleans, USA, May 2004 8) Naoto Kitajima, Syuchin Tei, Syunji Ohhara, Yoshifumi Inoue, Masaharu Miki, Toshiyuki Yamatani, Yoshikazu Kinoshita, Kazuaki Takahashi, Shunji Mishiro: Zoonotic transmission of hepatitis E virus from deer to human beings. DIGESTIVE DISEASE WEEK 2004. New Orleans, USA, May 2004 9),,,,,, :.., 2003 4 11

10),, : Nocturnal gastric acid breakthrough NAB.., 2003 4 11),,,,,,,,,, : Regenerating gene REG.., 2003 4 12),,,,,,,,,, : DSS Midkine RPTA-beta.., 2003 4 13),,,,,,,,,,,,,, : HP.., 2003 4 14),, : Toll dextran sodium sulfate DSS.., 2003 4 15),,,,,,,,,,,,,,,,,, : 3 PPI.., 2003 4 16),,, : Peroxisome proliferator-activated receptor PPAR.., 2003 4 17),,,,,, : ERCP.., 2003 5 18),,,,,,,,, : Barrett surveillance.., 2003 5 19),,,,,,,,,,, : CT.., 2003 5 20),,,,,,, 12

,,, :.., 2003 5 21),,,,,,,,,,,,,,, :.., 2003 6 22),,,,,,, : E HEV.., 2003 6 23),,,,,,,,,,,, :. 90., 2003 7 24),,,,, : late parenchymal phase.., 2003 9 25),, : Functional dyspepsia Functional dyspepsia 45., 2003 10 26),, : Toll-like receptor-4 MD-2 H. pylori. 45., 2003 10 27),,,,,,,,, : PPI H2RA. 45., 2003 10 28),, : 400 retrospective study.., 2003 10 29),, : Barrett Barrett's surveillance., 45., 2003 10 30),,,,,,,,,, : Barrett.., 2003 10 13

31),, : C IFN 2b ribavirin.., 2003 12 32),,,,,,,,,,,,, :. 80., 2003 12 33),,,,,,,,,,,,, : EUS-FNAB MALT. 91., 2003 12 34),,,,,,,,,,,, : EUS-FNAB malignant lymphoma.., 2003 12 35),,,,,,,,,,,, :. 91., 2003 12 36),,,,,,,,,,, :.., 2003 12 37),,,,,,,,,,,,,, :. 80., 2003 12 38),,,,,,,,,,, :. 80., 2003 12 39),,,,,,,,,, : 1. 80., 2003 12 40),,,,,,,,,,, :.., 2003 12 14

41), :.., 2003 12 42),, : E zoonosis. 90., 2004 4 43),,,,,,,,,,, :. 90., 2004 4 44),, : Barrett Barrett COX2. 90., 2004 4 45),,,,,,,,,,, : H. pylori H2. 90., 2004 4 46),,,,,,,,, : Body composition analyzer In body 2.0. 90., 2004 4 47),,,,,, :. 90., 2004 4 48),, : REG regeneration gene. 90., 2004 4 49),,,,,,,,, : H. pylori IL-8 REG. 90., 2004 4 50),, Mohammad A. K. umi, esar F. Ortega-Cava,, : histidine decarboxylas vesicular monoamina transporter 2. 90., 2004 4 51),,,,,,, 15

,,,,,, : Barrett pit pattern. 67., 2004 5 52),,,,,,,,,, :. 67., 2004 5 53),,,,,,,,, : NSAIDs ulcer. 67., 2004 5 54),,,,,,, :. 90., 2004 5 55),,,,,,,,, :. 81., 2004 6 56),,,,,,,,,,, :. 81., 2004 6 57),, : 24 ph GERD.., 2004 6 58),,,,,,,,,,, : 1.., 2004 7 59),,,,,,,,,,,,,, : EUS-FNAB.., 2004 7 60),,,,,,, :. 17., 2004 8 61),,,,,,,,, : H2-receptor antagonist PPI crossover. 46., 2004 16

10 62),, : GERD GERD. 46, 68., 2004 10 63),,,,,,,,,,,,,,,,,, : DSS. 46., 2004 10 64),, : Barrett Barrett Barrett. 46, 68., 2004 10 65),,,, :. 68., 2004 10 66),,,,,,,,, : Barrett. 68., 2004 10 67),,,,,,,,, : X 1. 91., 2004 11 68),,,,,,,,,,,,,,, : 1. 82., 2004 12 69),,,,,,,,,,,,,, : Solitary fibrous tumor. 82., 2004 12 17